People · Operator
Named in public records as an officer, director or promoter · active 2019–2020 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Guide Therapeutics, Inc. | — | Pharma | Series A | $13.9M | $173.6M | 2019 |
James Dahlman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Dahlman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Perlman | 1 | 15 |
| Julie Sunderland | 1 | 5 |
| Robert Hershberg | 1 | 3 |
| Thomas Reese Saylor | 1 | 1 |
| James Reese Dahlman | 1 | 1 |
| Andrew Reese Perlman | 1 | 1 |
| Boris Reese Nikolic | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.